Adding the immune checkpoint inhibitors (ICIs) ipilimumab and nivolumab to percutaneous hepatic perfusion may improve survival outcomes in patients with ...
LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of difficult-to-treat solid tumors through its proprietary RenovoRx ...
MedPage Today on MSN
Dual immunotherapy and liver perfusion delays progression in uveal melanoma
Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...
One treatment-related death occurred in the combination therapy group.
MOUNTAIN VIEW, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a life-sciences company developing innovative targeted oncology therapies and ...
A new study led by researchers at Baylor College of Medicine found that the use of a take-home electrical stimulation device improved muscle perfusion, the rate at which oxygen is delivered to muscles ...
A Chinese research team has used a gene-edited pig liver in an extracorporeal perfusion therapy to treat a patient with acute liver failure. The process saved the patient's life and significantly ...
First commercially available cell culture solution for HEK293 cells and perfusion -– optimized for high cell density (HCD), intensified processes and perfusion cultures Additional capabilities for ...
FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results